|
市場調査レポート
商品コード
1547678
血管損傷治療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測Global Vascular Injury Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
||||||
カスタマイズ可能
|
|||||||
| 血管損傷治療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測 |
|
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 170 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 図表
- 目次
血管損傷治療市場の世界需要は、調査期間2024～2032年のCAGR6.55%で、2023年の43億7,000万米ドルから2032年には約77億4,000万米ドルの市場規模に達すると推定されます。
血管損傷治療は、外傷や打撃による血管の損傷を治療するためのアプローチです。血管外傷は、血液を運ぶ動脈や静脈に軽微な損傷や重大な損傷を引き起こす可能性があります。血管外傷の最も一般的な症状は、出血、打撲、骨折です。これらの損傷は動脈、リンパ系、静脈系に影響し、下肢に生じることが多いです。治療の選択肢としては、血管内治療、筋膜切開術、血管再建を伴う外科手術などがあります。血管損傷治療には多くの治療と診断上の課題があります。血管損傷はあらゆる年齢層で起こりうるが、最も悲惨なのは小児です。
市場力学
この急速な工業化時代における主要な死因の一つである外傷は、この市場成長の主要原動力です。適切かつタイムリーな治療を可能にする、迅速で信頼性の高い血管損傷診断の必要性が、市場成長に寄与します。定期的なテロ攻撃により、世界的に民間人の死傷者数が増加していることが市場成長を後押しします。医療支出の増加、救急救命士のトレーニング向上が市場成長をさらに促進します。血管外傷の犠牲者を治療するための最適化されたケアと技術の進歩は、市場の後押しとなると考えられます。この市場が直面する主要課題は、外傷の診断の時期尚早や見逃しです。
調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは血管損傷治療の世界市場における各セグメントを包括的に評価することもできます。血管損傷治療産業の成長と動向は、この調査に全体的なアプローチを記載しています。
市場セグメンテーション
血管損傷治療市場レポートのこのセクションでは、国と地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家が今後の機会でそれぞれの製品やサービスの対象層を特定するのに役立ちます。
地域別分析
このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける血管損傷治療市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。
カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。
目次
第1章 序文
第2章 エグゼクティブサマリー
- 市場のハイライト
- 世界市場スナップショット
第3章 血管損傷治療-産業分析
- イントロダクション：市場力学
- 市場促進要因
- 市場抑制要因
- 市場機会
- 業界動向
- ポーターのファイブフォース分析
- 市場の魅力分析
第4章 バリューチェーン分析
- バリューチェーン分析
- 原材料分析
- 原材料リスト
- 原材料メーカー一覧
- 主要原材料の価格動向
- 潜在的バイヤー一覧
- マーケティングチャネル
- 直接マーケティング
- 間接マーケティング
- マーケティングチャネル発展動向
第5章 血管損傷治療の世界市場分析：損傷別
- 損傷別概要
- 損傷別過去・予測データ分析
- 痙攣
- 血栓症
- 挫傷/内膜フラップ
- 裂傷/断裂
- 動静脈（AV）瘻
- 動脈瘤と偽動脈瘤
- その他
第6章 血管損傷治療の世界市場分析：治療別
- 治療別概要
- 治療別過去・予測データ分析
- 側方前膜切除術/静脈瘤切除術
- 解剖学的外バイパス術
- パッチ血管形成術
- バイパスグラフト
- 血栓除去術
- その他
第7章 血管損傷治療の世界市場分析：エンドユーザー別
- エンドユーザー別概要
- エンドユーザー別過去・予測データ分析
- 病院
- 外来手術センター
- その他
第8章 血管損傷治療の世界市場分析：地域別
- 地域別展望
- イントロダクション
- 北米売上分析
- 概要、実績と予測
- 北米：セグメント別
- 北米：国別
- 米国
- カナダ
- メキシコ
- 欧州売上分析
- 概要、実績と予測
- 欧州：セグメント別
- 欧州：国別
- 英国
- フランス
- ドイツ
- イタリア
- ロシア
- その他の欧州
- アジア太平洋売上分析
- 概要、実績と予測
- アジア太平洋：セグメント別
- アジア太平洋：国別
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- 東南アジア
- その他のアジア太平洋
- ラテンアメリカ売上分析
- 概要、実績と予測
- ラテンアメリカ：セグメント別
- ラテンアメリカ：国別
- ブラジル
- アルゼンチン
- ペルー
- チリ
- その他のラテンアメリカ
- 中東・アフリカ売上分析
- 概要、実績と予測
- 中東・アフリカ：セグメント別
- 中東・アフリカ：国別一覧
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他の中東・アフリカ
第9章 血管損傷治療企業の競合情勢
- 血管損傷治療市場の競合
- 提携・協力・契約
- 合併・買収
- 新製品発売
- その他の開発
第10章 企業プロファイル
- 上位企業の市場シェア分析
- 市場集中度
- Cleveland Clinic
- Apollo Hospitals Enterprise Ltd.
- Massachusetts General Hospital
- Heidelberg University Hospital
- Royal Berkshire NHS Foundation Trust
- Universal Health Services Inc.
- Tenet Healthcare
- Mayo Clinic Health System
- Mediclinic International
- CHSPSC LLC
- IHH Healthcare Berha
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Injury (USD MN)
- Spasm Market Sales By Geography (USD MN)
- Thrombosis Market Sales By Geography (USD MN)
- Contusion/Intimal Flap Market Sales By Geography (USD MN)
- Laceration/Transection Market Sales By Geography (USD MN)
- Arteriovenous (AV) Fistula Market Sales By Geography (USD MN)
- Aneurysm and Pseudoaneurysm Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Analysis By Treatment (USD MN)
- Lateral Arteriorrhaphy/Venorrhaphy Market Sales By Geography (USD MN)
- Extra Anatomic Bypass Market Sales By Geography (USD MN)
- Patch Angioplasty Market Sales By Geography (USD MN)
- Bypass Graft Market Sales By Geography (USD MN)
- Thrombectomy Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Analysis By End User (USD MN)
- Hospitals Market Sales By Geography (USD MN)
- Ambulatory Surgical Centers Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Vascular Injury Treatment Market Sales By Geography (USD MN)
- North America Market Analysis (USD MN)
- United States Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate By Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Vascular Injury Treatment Report
- Market Research Process
- Market Research Methodology
- Global Vascular Injury Treatment Market Size, By Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Injury
- Market Attractiveness Analysis By Treatment
- Market Attractiveness Analysis By End User
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Injury (USD MN)
- Spasm Market Sales By Geography (USD MN)
- Thrombosis Market Sales By Geography (USD MN)
- Contusion/Intimal Flap Market Sales By Geography (USD MN)
- Laceration/Transection Market Sales By Geography (USD MN)
- Arteriovenous (AV) Fistula Market Sales By Geography (USD MN)
- Aneurysm and Pseudoaneurysm Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Market Analysis By Treatment (USD MN)
- Lateral Arteriorrhaphy/Venorrhaphy Market Sales By Geography (USD MN)
- Extra Anatomic Bypass Market Sales By Geography (USD MN)
- Patch Angioplasty Market Sales By Geography (USD MN)
- Bypass Graft Market Sales By Geography (USD MN)
- Thrombectomy Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Market Analysis By End User (USD MN)
- Hospitals Market Sales By Geography (USD MN)
- Ambulatory Surgical Centers Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
The global demand for Vascular Injury Treatment Market is presumed to reach the market size of nearly USD 7.74 Billion by 2032 from USD 4.37 Billion in 2023 with a CAGR of 6.55% under the study period 2024-2032.
Vascular injury treatment is an approach used to treat an injury to the blood vessels caused due to a trauma or a blow. Vascular trauma can cause minor or significant damages to the blood carrying arteries and veins. The most common symptoms of vascular trauma are bleeding, bruising, and fractured bones. These injuries affect the arterial, lymphatic, or venous system and are most often located on a lower limb. Some of the treatment options available are endovascular treatment, fasciotomy, and surgical procedures involving vascular reconstruction. Many therapeutic and diagnostic challenges are involved in vascular injury treatment. Vascular injuries can occur in people of all ages and are the most devastating in children.
MARKET DYNAMICS
Trauma, one of the leading causes of death in this rapid industrialization era, is the main driver for this market's growth. The need for fast and reliable vascular injury diagnosis to enable proper and timely treatment will benefit market growth. The increase in the number of civilian casualties worldwide will boost market growth due to the regular terrorist attack. Growing healthcare spending, better paramedic training will further propel market growth. Optimized care and advancements in technology for treating victims of vascular trauma will be a market booster. The main challenge faced by this market is the untimely or missed diagnosis of the trauma.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Vascular Injury Treatment. The growth and trends of Vascular Injury Treatment industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Vascular Injury Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Injury
- Spasm
- Thrombosis
- Contusion/Intimal Flap
- Laceration/Transection
- Arteriovenous (AV) Fistula
- Aneurysm and Pseudoaneurysm
- Others
By Treatment
- Lateral Arteriorrhaphy/Venorrhaphy
- Extra Anatomic Bypass
- Patch Angioplasty
- Bypass Graft
- Thrombectomy
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Vascular Injury Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Vascular Injury Treatment market include Cleveland Clinic, Apollo Hospitals Enterprise Ltd., Massachusetts General Hospital, Heidelberg University Hospital, Royal Berkshire NHS Foundation Trust, Universal Health Services Inc., Tenet Healthcare, Mayo Clinic Health System, Mediclinic International, CHSPSC LLC, IHH Healthcare Berha. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. VASCULAR INJURY TREATMENT - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Injury
- 3.7.2 Market Attractiveness Analysis By Treatment
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL VASCULAR INJURY TREATMENT MARKET ANALYSIS BY INJURY
- 5.1. Overview By Injury
- 5.2. Historical and Forecast Data Analysis By Injury
- 5.3. Spasm Historic and Forecast Sales By Regions
- 5.4. Thrombosis Historic and Forecast Sales By Regions
- 5.5. Contusion/Intimal Flap Historic and Forecast Sales By Regions
- 5.6. Laceration/Transection Historic and Forecast Sales By Regions
- 5.7. Arteriovenous (AV) Fistula Historic and Forecast Sales By Regions
- 5.8. Aneurysm and Pseudoaneurysm Historic and Forecast Sales By Regions
- 5.9. Others Historic and Forecast Sales By Regions
6. GLOBAL VASCULAR INJURY TREATMENT MARKET ANALYSIS BY TREATMENT
- 6.1. Overview By Treatment
- 6.2. Historical and Forecast Data Analysis By Treatment
- 6.3. Lateral Arteriorrhaphy/Venorrhaphy Historic and Forecast Sales By Regions
- 6.4. Extra Anatomic Bypass Historic and Forecast Sales By Regions
- 6.5. Patch Angioplasty Historic and Forecast Sales By Regions
- 6.6. Bypass Graft Historic and Forecast Sales By Regions
- 6.7. Thrombectomy Historic and Forecast Sales By Regions
- 6.8. Others Historic and Forecast Sales By Regions
7. GLOBAL VASCULAR INJURY TREATMENT MARKET ANALYSIS BY END USER
- 7.1. Overview By End User
- 7.2. Historical and Forecast Data Analysis By End User
- 7.3. Hospitals Historic and Forecast Sales By Regions
- 7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
- 7.5. Others Historic and Forecast Sales By Regions
8. GLOBAL VASCULAR INJURY TREATMENT MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE VASCULAR INJURY TREATMENT COMPANIES
- 9.1. Vascular Injury Treatment Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10. COMPANY PROFILES OF VASCULAR INJURY TREATMENT INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Cleveland Clinic
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
- 10.4. Apollo Hospitals Enterprise Ltd.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
- 10.5. Massachusetts General Hospital
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
- 10.6. Heidelberg University Hospital
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
- 10.7. Royal Berkshire NHS Foundation Trust
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
- 10.8. Universal Health Services Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
- 10.9. Tenet Healthcare
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
- 10.10. Mayo Clinic Health System
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
- 10.11. Mediclinic International
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
- 10.12. CHSPSC LLC
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
- 10.13. IHH Healthcare Berha
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
